These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37849642)

  • 1. Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer.
    Abduh MS
    Int J Nanomedicine; 2023; 18():5713-5732. PubMed ID: 37849642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
    Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A
    Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach.
    Naseer F; Ahmad T; Kousar K; Kakar S; Gul R; Anjum S; Shareef U
    Int J Nanomedicine; 2023; 18():185-205. PubMed ID: 36643861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
    Kousar K; Naseer F; Abduh MS; Anjum S; Ahmad T
    Front Immunol; 2023; 14():1175535. PubMed ID: 37283735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
    Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma.
    Kousar K; Naseer F; Abduh MS; Kakar S; Gul R; Anjum S; Ahmad T
    Front Pharmacol; 2022; 13():1073004. PubMed ID: 36712656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment.
    Xu Y; Liu D; Hu J; Ding P; Chen M
    Int J Pharm; 2020 Jan; 573():118637. PubMed ID: 31550511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
    Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
    Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
    Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
    Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer.
    Wang Z; Sau S; Alsaab HO; Iyer AK
    Nanomedicine; 2018 Jun; 14(4):1441-1454. PubMed ID: 29678787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.
    Sharma R; Yadav V; Jha S; Dighe S; Jain S
    Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
    Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
    Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
    Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
    Wang S; Zhang J; Wang Y; Chen M
    Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 targeted redox-triggered self-assembly with magnetic enhanced EPR effects for effective amplification of gambogic acid to treat triple-negative breast cancer.
    Sang M; Han L; Luo R; Qu W; Zheng F; Zhang K; Liu F; Xue J; Liu W; Feng F
    Biomater Sci; 2019 Dec; 8(1):212-223. PubMed ID: 31674634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative and Apoptotic Effects of pH-Responsive Veratric Acid-Loaded Polydopamine Nanoparticles in Human Triple Negative Breast Cancer Cells.
    Harini G; Shree Ganesh S; Anushikaa R; Bharathi R; Aravind S; Vatsala K; Shanmugavadivu A; Selvamurugan N
    Chem Biodivers; 2023 Jun; 20(6):e202201006. PubMed ID: 37140976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
    Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
    Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing and Formulation Optimization of Hyaluronic Acid Conjugated PLGA Nanoparticles of Tamoxifen for Tumor Targeting.
    Paswan SK; Saini TR; Jahan S; Ganesh N
    Pharm Nanotechnol; 2021; 9(3):217-235. PubMed ID: 33745427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.